Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business
HONG KONG, April 2, 2015 /PRNewswire/ -- Jintian Pharmaceutical Group Limited ("Jintian Pharmaceutical" or the "Company"; stock code: 2211) announced that Mr. Jin Dongtao, chairman and executive director purchased 40,000,000 ordinary shares (the "shares") of the Company, representing 2% of the existing entire issued share capital of the Company from AMG Holdings Limited, at HK$2.82 per share with the total amount of approximately HK$113 million. Upon the completion of the transaction, Mr. Jin Dongtao's shareholding will increase from 45.17% to 47.17%.
Photo - http://photos.prnewswire.com/prnh/20150401/195932
Mr. Jin Dongtao's explanation of the increase of shareholding will better interpret the Company's strategic conception:
Great confidence in the development of China's MacroHealth industry.
With China entering aging society, MacroHealth industry, strongly supported by the nation, enjoys huge development potential. Jintian Pharmaceutical, as the forerunner in the pharmaceutical distribution industry, takes the lead in implementing layout of MacroHealth industry with its extraordinary healthcare entity network.
Great confidence in the development of cross-border trading.
By the international perspective resulted from listing in Hong Kong, on one hand, through distributing and selling international MacroHealth brands' products, the Company achieved strategic cooperation with multiple world-renowned manufactures, expanded the market for the products, and improved profitability and competitiveness among domestic peers; on the other hand, the Company follows closely with the development of free trade zones in China and arrange its business accordingly, in the future the Company will enter the international market to cooperate with famous enterprises around the world, so as to establish overseas MacroHealth brand operation and management enterprise.
Great confidence in the establishment of mobile internet platforms.
The Chinese government revealed "Internet Plus" strategy recently, which brought huge development potential for the industry. During 2014, after cooperation with Ali Health, the Company introduced elite teams from the Internet field to actively develop retail and distribution network, and to establish competitive O2O platform. The Company combines with advantages of its entity network to promote fast implementation of our e-commerce strategy to best leverage our leading real economy advantage.
Mr. Jin Dongtao mentioned, "CVC Capital Partners, as one of our main pre-ipo private fund investors, their lock-up period has expired after three and a half years' holding period. This transaction is a win-win investment decision. We express the most sincere gratitude for their years of support."
CONTACT: +852-3970-2290
